PPIDT00412
Drug Information
| Name | Margetuximab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB14967 |
| Type | biotech |
| Indication | Margetuximab is an anti-HER2 monoclonal antibody indicated, in combination with chemotherapy, for the treatment of metastatic HER2-positive breast cancer in adult patients who have received two or more prior anti-HER2 regimens with at least one prior regimen for metastatic disease.[L27986] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution, concentrate | Intravenous |
25 mg/1mL
|